Adiponectin in essential hypertension

Journal of Nephrology

Volumn 15, Issue 5, 2002, Pages 507-511

  Mallamaci, Francesca ^b   Zoccali, Carmine ^a   Cuzzola, Fortunata ^b   Tripepi, Giovanni ^b   Cutrupi, Sebastiano ^b   Parlongo, Saverio ^b   Tanaka, Sachiyo ^c   Ouchi, Noriyuki ^c   Kihara, Shinji ^c   Funahashi, Tohru ^c   Matsuzawa, Yuji ^c  

^a BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^b CNR   (Italy)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Adiponectin; Diabetes; Hypertension; Insulin sensitivity; Leptin

Indexed keywords

ADIPONECTIN; ADIPOSE MOST ABUNDANT GENE TRANSCRIPT 1; CHOLESTEROL; COLLAGEN DERIVATIVE; CREATINE; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; SECRETORY PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD LEVEL; BODY FAT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CREATININE CLEARANCE; ENDOTHELIUM LESION; ESSENTIAL HYPERTENSION; FEMALE; GENDER; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY FUNCTION; MALE; MULTIPLE REGRESSION; PLASMA; PREDICTION; PROTEIN SYNTHESIS; STATISTICAL SIGNIFICANCE;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; AGE FACTORS; ANTHROPOMETRY; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; BODY MASS INDEX; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; PROTEINS; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 0036760026     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001; 60: 349-56.
2. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996; 221: 286-9.
3. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473-6.
4. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-9.
5. Segal KR, Van Loan M, Fitzgerald PI, Hodgdon JA, Van Itallie TB. Lean body mass estimation by bioelectrical impedance analysis: A four-site cross-validation study. Am J Clin Nutr 1988; 47: 7-14.
6. Bonora E, Kiechl S, Willeit J, Oberhollenzer F,Egger G, Tagher G. Prevalence of insulin resistance in metabolic disorders: The Bruneck Study. Diabetes 1998; 47: 1643-9.
7. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83.
8. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-5.
9. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 134-41.
10. Yang SW, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: 3815-9.
11. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002; 360: 57-8.
12. Mallamaci F, Cuzzola F, Tripepi G, Cutrupi S, Parlongo S, Tripepi R. Gender-dependent differences in plasma leptin in essential hypertension. Am J Hypertens 2000; 13: 914-20.
13. Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002; 87: 2764-9.
14. Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002; 13: 745-53.
15. Mallamaci F, Panuccio V, Tripepi G, Cutrupi S, Parlongo S, Catalano F, Tanaka S, Funahashi T, Ouchi N, Shinji K, Matsuzawa Y, Zoccali C. Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. XXXIX ERA-EDTA Congress 2002, Copenhagen-Denmark (Abstract)
16. Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G. Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 2002; 25: 971-6.